Intellia Therapeutics Inc.



Before the Bell

 --Quotes are delayed by 20 min

Jun 27, 2022, 7:24 a.m.





+0.48 +0.90%


Volume 421

Quotes are delayed by 20 min


Previous close

$ 53.41

$ 53.41


+2.65 +5.22%

Day low

Day high




52 week low

52 week high




Jean-Francois B. Formela

Jean-Francois B. Formela founded 7 companies, which include: Translate Bio, Inc., ArQule, Inc. and Adnexus. Currently, he is Chairman for Triplet Therapeutics, Inc. (which he founded) and Partner at Atlas Venture, Inc. Dr. Formela is also Member of Massachusetts General Hospital Clinical Research Program and on the board of 20 other companies.

Dr. Formela previously held the position of Chairman of Zyla Life Sciences, Inc., Chairman of Egalet Ltd., Senior Director-Medical Marketing at Schering-Plough Corp., Director at ArQule, Inc., Director at Arteaus Therapeutics LLC, Independent Director at Translate Bio, Inc. and Director at Adnexus.

Jean-Francois B. Formela received a doctorate from Université de Paris XI Paris Sud and an MBA from The Trustees of Columbia University in The City of New York.


Date Shares Transaction Value
06/14/2022 5,197   Award at $0 per share. 0
06/23/2021 2,094   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.